Hege Hellstrom
Director/Board Member at VIVESTO AB
Net worth: 179 539 $ as of 2024-05-30
Network origin in Hege Hellstrom first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 | |
24
| Public Company | Pharmaceuticals: Major | 24 |
22
| Public Company | Pharmaceuticals: Generic | 22 |
15
| Public Company | Biotechnology | 15 |
14
| Public Company | Pharmaceuticals: Generic | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hege Hellstrom via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
| HOIST FINANCE AB | Miscellaneous Commercial Services | Director/Board Member Comptroller/Controller/Auditor Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Public Communications Contact | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman | |
| OREXO AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Copenhagen Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chairman Chief Executive Officer | |
| University of St. Gallen | College/University | Masters Business Admin Graduate Degree | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Investor Relations Contact | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Chairman Founder Founder Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member General Counsel | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Chairman | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director of Finance/CFO Director/Board Member | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| Scibase AB | Director/Board Member Director/Board Member | ||
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Karin & Sten Morsedt Cbd Solutions AB
 Karin & Sten Morsedt Cbd Solutions AB Miscellaneous Commercial ServicesCommercial Services Karin & Sten Morsedt Cbd Solutions AB provides research services to cure corticobasal degeneration disease. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
Camurus Ltd.
 Camurus Ltd. Medical DistributorsDistribution Services Part of Camurus AB, Camurus Ltd. is a wholesaler of pharmaceutical goods. The company is based in Duxford, UK. Camurus was founded in 2017. | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 28 |
| France | 7 |
| Denmark | 6 |
| Switzerland | 5 |
| United States | 4 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 2 |
Operational
| Director/Board Member | 412 |
| Corporate Officer/Principal | 190 |
| Chairman | 117 |
| Independent Dir/Board Member | 111 |
| Chief Executive Officer | 100 |
Most connected contacts
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Marianne Dicander Alexandersson | 36 |
| Bo Jesper Hansen | 34 |
| Nicolas Fulpius | 34 |
| Stig Anders Lindberg | 31 |
| Folke Per-Olof Wallström | 30 |
| Gunilla Öhman | 29 |
| Birgit Stattin Norinder | 29 |
| Isak Peter Zonabend | 27 |
| Urban Paulsson | 25 |
| Philippe Boucheron | 24 |
| Karl Härfstrand | 23 |
| Catherine Dunand | 23 |
| David Solomon | 22 |
| Jeff Jonas | 21 |
- Stock Market
- Insiders
- Hege Hellstrom
- Company connections
